GlassScriptPhysician profile
Thomas Kent Donaldson
NPI 1457315269
$892,842.67
in general payments reported to CMS, 2019-2025
11 companies · $75K in 2025
The $75K reported for 2025 was more than what 90% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284K · 2020: $208K · 2021: $165K · 2022: $106K · 2023: $36K · 2024: $20K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $83K · Royalty Or License: $32K · Travel and Lodging: $13K · Food and Beverage: $2,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,325.00 |
| Royalty Or License | $32,155.77 |
| Travel and Lodging | $13,060.53 |
| Food and Beverage | $2,173.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $810,179.97 | 2019-2025 | Arcos, Arcos Revision Hip Instrumentation, G7 |
| Kyocera Medical Technologies, INC. | $72,592.17 | 2024-2025 | |
| Exactech, INC. | $8,563.88 | 2019-2024 | |
| Medacta USA, INC. | $915.18 | 2019-2024 | Gmk Sphere, Amistem |
| Ossur Americas, INC. | $261.46 | 2025 | Unloader One X |
| Bodycad USA Corp | $153.37 | 2019 | |
| Stryker Corporation | $94.42 | 2022-2025 | Mako |
| Medtronic, INC. | $23.24 | 2024 | Mazor X System |
| Abbvie INC. | $22.42 | 2024 | |
| Boston Scientific Corporation | $19.26 | 2023 | |
| Trevena, INC. | $17.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Donaldson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.